Julia Dorn
Impact in
- Genetics top 2%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms
- Cancer-related molecular mechanisms research
Papers in
- Co-authors
- Manfred Schmitt (28 shared papers)Eleftherios P. Diamandis (23 shared papers)Barbara Schmalfeldt (15 shared papers)Nadia Harbeck (16 shared papers)Andreas Scorilas (17 shared papers)Marion Kiechle (27 shared papers)Viktor Magdolen (33 shared papers)Carla A. Borgoño (5 shared papers)
In The Last Decade
Julia Dorn
56 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 99
- Genetics 575
- Cancer Research 401
- Oncology 634
- Hematology 241
- Immunology and Allergy 88
Countries citing papers authored by Julia Dorn
This map shows the geographic impact of Julia Dorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Dorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Dorn more than expected).
Fields of papers citing papers by Julia Dorn
This network shows the impact of papers produced by Julia Dorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Dorn. The network helps show where Julia Dorn may publish in the future.
Co-authors
The 25 scholars most cited alongside Julia Dorn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 199 | |
| 2 | Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer. | 2003 | 114 |
| 3 | 2011 | 80 | |
| 4 | Human kallikrein 8, a novel biomarker for ovarian carcinoma. | 2003 | 73 |
| 5 | 2013 | 62 | |
| 6 | 2004 | 62 | |
| 7 | 2006 | 52 | |
| 8 | 2020 | 49 | |
| 9 | 2003 | 44 | |
| 10 | 2004 | 41 | |
| 11 | 2021 | 40 | |
| 12 | 2010 | 38 | |
| 13 | 2013 | 35 | |
| 14 | 2011 | 34 | |
| 15 | 2016 | 33 | |
| 16 | 2012 | 33 | |
| 17 | 2018 | 29 | |
| 18 | 2016 | 29 | |
| 19 | 1969 | 24 | |
| 20 | 2014 | 24 |
About Julia Dorn
Julia Dorn is a scholar working on Genetics, Oncology, Molecular Biology, Hematology and Cancer Research, having authored 57 papers that have together received 1.5k indexed citations. Recurring topics across this work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (34 papers), Peptidase Inhibition and Analysis (23 papers), Blood Coagulation and Thrombosis Mechanisms (17 papers), Phytochemical compounds biological activities (11 papers), MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (4 papers), Cancer-related molecular mechanisms research (4 papers) and Cell Adhesion Molecules Research (3 papers). The work is most often cited by research in Genetics (575 citations), Cancer Research (401 citations), Oncology (634 citations), Hematology (241 citations) and Immunology and Allergy (88 citations). Julia Dorn has collaborated with scholars based in Germany, Canada and Greece. Frequent co-authors include Manfred Schmitt, Eleftherios P. Diamandis, Barbara Schmalfeldt, Nadia Harbeck, Andreas Scorilas, Marion Kiechle, Viktor Magdolen, Carla A. Borgoño, Holger Bronger and Ulrich Hübscher. Their work appears in journals such as Biological Chemistry, Clinical Cancer Research, Annals of Oncology, Clinical Biochemistry and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.